PIM
ZYME icon

Plato Investment Management’s Zymeworks ZYME Stock Holding History

Plato Investment Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,088
Closed -$21.7K – 516
2023
Q4 		$21.7K Buy
+2,088
New +$16.6K 0.03% 310

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Plato Investment Management's ZYME Position: Q1 2024 in Review

Plato Investment Management sold out of Zymeworks (ZYME) in Q1 2024, closing a stake of 2,088 shares — an estimated $21.7K sold.

Plato Investment Management first reported a position in ZYME in Q4 2023 and held it in 1 quarter. The position peaked at $21.7K in Q4 2023. 171 funds tracked by Wall St. Rank hold ZYME as of Q1 2024.

  • Plato Investment Management reported no remaining Zymeworks position as of Q1 2024 after selling out during the quarter.
  • Plato Investment Management sold 2,088 Zymeworks shares in Q1 2024, an estimated $21.7K.
  • Plato Investment Management first reported a position in Zymeworks in Q4 2023 and held it in 1 quarter.
  • Plato Investment Management's Zymeworks position peaked at $21.7K in Q4 2023.
  • 171 funds tracked by Wall St. Rank held Zymeworks as of Q1 2024.

Based on Plato Investment Management's 13F filing for Q1 2024, filed 15 May 2024.